SYSTEMIC LUPUS ERYTHEMATOSUS COMPLICATED WITH CASTLEMAN DISEASE : A CASE REPORT
Castleman disease is a rare nonclonal heterogeneous group of diseases involving lymphoid tissue. It often simulates other inflammatory conditions and malignancies.
Suhail Iqbal +3 more
core +1 more source
Margaret Castleman, \u2769 (BardCorps)
Margaret Castleman recalls her arrival at Bard in the mid-sixties as a preppy dance student, and getting swept up in the whole hippie thing ; choosing the theater program over dance; feeling lost and undirected after dropping out for a semester ...
Castleman, Margaret
core +1 more source
IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE
Idiopathic multicentric Castleman disease (IMCD) is a rare and complex lymphoproliferative disorder characterized by excessive growth of polyclonal, reactive lymphoid cells in multiple lymph nodes, often associated with systemic symptoms such as fever ...
A. Di Napoli, S. Ferrero
core
Multidisciplinary Collaborative Treatment of Mediastinal Castleman Disease: A Case Report. [PDF]
Lang Y, Yao J.
europepmc +1 more source
Unicentric Castleman Disease Involving the Submandibular Gland: A Case Report. [PDF]
Sun X +5 more
europepmc +1 more source
Spinal Castleman disease: An imposter-A rare case from Ethiopia. [PDF]
Getu FK +6 more
europepmc +1 more source
Unicentric Adrenal Castleman Disease Mimicking an Adrenal Tumour. [PDF]
Han LA, Naung Y.
europepmc +1 more source
Brief communication: rituximab in HIV-associated multicentric castleman disease
Background: HIV-associated multicentric Castleman disease is a rare lymphoproliferative disorder with marked systemic symptoms attributed to cytokine disarray.
Mark Nelson (213425) +12 more
core
The Utility of IgG4/IgG Ratio in the Diagnosis of Multicentric Castleman Disease: A Case Report of HHV8+ Castleman Disease in a Patient with Classical Hodgkin's Lymphoma. [PDF]
Hagele A +6 more
europepmc +1 more source
Oligocentric Castleman Disease (OligoCD): A Novel Diagnostic Entity in the Spectrum of Castleman Disease. [PDF]
Baisya R, Nehil J, Dagar V, Manna S.
europepmc +1 more source

